WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011144724) A PHARMACEUTICAL CONTROLLED RELEASE COMPOSITION OF LOSARTAN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/144724    International Application No.:    PCT/EP2011/058229
Publication Date: 24.11.2011 International Filing Date: 20.05.2011
IPC:
A61K 9/20 (2006.01), A61K 9/28 (2006.01), A61K 31/4178 (2006.01)
Applicants: LABORATORIOS LICONSA, S.A. [ES/ES]; Gran Via Carles III, 98 Ed. Trade E-08028 Barcelona (ES) (For All Designated States Except US).
SERENO GUERRA, Antonio [BE/BE]; (BE) (For US Only).
LOECHES BLAS, David [ES/ES]; (ES) (For US Only).
VARAS FERNANDEZ-MOLINA, Roberto [ES/ES]; (ES) (For US Only).
DEL CURA MEDINA, Estibaliz [ES/ES]; (ES) (For US Only).
RIZO MARTÍNEZ, José Miguel [ES/ES]; (ES) (For US Only)
Inventors: SERENO GUERRA, Antonio; (BE).
LOECHES BLAS, David; (ES).
VARAS FERNANDEZ-MOLINA, Roberto; (ES).
DEL CURA MEDINA, Estibaliz; (ES).
RIZO MARTÍNEZ, José Miguel; (ES)
Agent: ZBM Patents- Zea, Barlocci & Markvardsen; Pl. Catalunya, 1 E-08002 Barcelona (ES)
Priority Data:
10382135.1 21.05.2010 EP
Title (EN) A PHARMACEUTICAL CONTROLLED RELEASE COMPOSITION OF LOSARTAN
(FR) COMPOSITION PHARMACEUTIQUE À LIBÉRATION CONTRÔLÉE À BASE DE LOSARTAN
Abstract: front page image
(EN)The present invention relates to a controlled release pharmaceutical composition of losartan which comprises a gastric retained core with losartan and an amount comprised between 5 and 25% by weight of hydroxypropyl methylcellulose as a unique controlled release polymer, and an active immediate release layer containing losartan, to its preparation process and its use for the prophylaxis and treatment of hypertension.
(FR)La présente invention concerne une composition pharmaceutique à libération contrôlée à base de losartan comprenant un noyau central gastrorésistant contenant du losartan et une quantité comprise entre 5 et 25 % en poids d'hydroxypropylméthylcellulose qui constitue l'unique polymère assurant la libération contrôlée. Ladite composition comprend également une couche active à libération immédiate contenant du losartan. L'invention concerne, en outre, le procédé de préparation de ladite composition et son utilisation en vue de la prophylaxie et du traitement de l'hypertension.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)